Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes—results from the NOR-Gout study

Patients with gout need to adhere to medication over time to achieve good outcomes. We assessed self-reported adherence to medication with urate lowering therapy (ULT) 5 years after a treat-to-target intervention and studied how non-adherence was related to baseline demographic and disease variables.